# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-23-021531
Filing Date
2023-04-28
Accepted
2023-04-28 16:10:22
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20007889x2_defa14a.htm | DEFA14A | 13397
2 |  | ny20007889x2-nc_01.jpg | GRAPHIC | 916970
3 |  | ny20007889x2-nc_02.jpg | GRAPHIC | 767132
| Complete submission text file | 0001140361-23-021531.txt |  | 2261952

Mailing Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538
Business Address 47215 LAKEVIEW BOULEVARD FREMONT CA 94538 (877) 922-9835
Cytek Biosciences, Inc. (Filer) CIK: 0001831915 (see all company filings)

EIN.: 472547526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40632 | Film No.: 23866149
SIC: 3826 Laboratory Analytical Instruments